TRK-IN-15

• CAS Number:

  1365213-20-2

• UNSPSC Description:

  TRK-IN-15 is a potent inhibitor of TRK. Protein kinases play a critical role in the control of cell growth and differentiation and are responsible for the control of a wide variety of cellular signal transduction processes. TRK-IN-15 has the potential for the research of TRK-related diseases (extracted from patent WO2012034091A1, compound X-55)[1].

• Target Antigen:

  Trk Receptor

• Type:

  Reference compound

• Related Pathways:

  Neuronal Signaling;Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/trk-in-15.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CCNC(C1=CN=C2N1N=C(N3[C@](C4=CC(F)=CC=C4)([H])CCC3)C=C2)=O

• Molecular Weight:

  353.39

• References & Citations:

  [1] Yi Fan, et al. Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors. Patent WO2012034091A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported